Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro. (Q39346958)
Jump to navigation
Jump to search
scientific article published on May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro. |
scientific article published on May 2012 |
Statements
Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro (English)
Hongyu Liu
Christian Scholz
Chuanbing Zang
Jan H Schefe
Piet Habbel
Anne-Constanze Regierer
Carsten-Oliver Schulz
Kurt Possinger